rs869312865

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PM5

The NM_007327.4(GRIN1):​c.679G>A​(p.Asp227Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000000691 in 1,448,130 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D227H) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

GRIN1
NM_007327.4 missense

Scores

4
12
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 6.22

Publications

2 publications found
Variant links:
Genes affected
GRIN1 (HGNC:4584): (glutamate ionotropic receptor NMDA type subunit 1) The protein encoded by this gene is a critical subunit of N-methyl-D-aspartate receptors, members of the glutamate receptor channel superfamily which are heteromeric protein complexes with multiple subunits arranged to form a ligand-gated ion channel. These subunits play a key role in the plasticity of synapses, which is believed to underlie memory and learning. Cell-specific factors are thought to control expression of different isoforms, possibly contributing to the functional diversity of the subunits. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
GRIN1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
  • developmental and epileptic encephalopathy 101
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr9-137156676-G-C is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 224815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIN1NM_007327.4 linkc.679G>A p.Asp227Asn missense_variant Exon 5 of 20 ENST00000371561.8 NP_015566.1 Q05586-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN1ENST00000371561.8 linkc.679G>A p.Asp227Asn missense_variant Exon 5 of 20 1 NM_007327.4 ENSP00000360616.3 Q05586-1

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD2 exomes
AF:
0.00000446
AC:
1
AN:
224368
AF XY:
0.00000819
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000101
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.91e-7
AC:
1
AN:
1448130
Hom.:
0
Cov.:
34
AF XY:
0.00000139
AC XY:
1
AN XY:
719300
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33250
American (AMR)
AF:
0.00
AC:
0
AN:
43508
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25854
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39110
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84130
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50212
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5368
European-Non Finnish (NFE)
AF:
9.03e-7
AC:
1
AN:
1106914
Other (OTH)
AF:
0.00
AC:
0
AN:
59784
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Oct 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GRIN1: PM2, PP2, PP3 -

Jul 08, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant Uncertain:1
Oct 17, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GRIN1 protein function. This variant has not been reported in the literature in individuals affected with GRIN1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 227 of the GRIN1 protein (p.Asp227Asn). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.86
BayesDel_addAF
Uncertain
0.046
T
BayesDel_noAF
Benign
-0.17
CADD
Pathogenic
34
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.74
D;.;.;T;.;.;.
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.96
D;D;D;D;D;D;D
M_CAP
Pathogenic
0.57
D
MetaRNN
Uncertain
0.59
D;D;D;D;D;D;D
MetaSVM
Uncertain
0.48
D
MutationAssessor
Benign
1.6
L;L;.;.;.;L;.
PhyloP100
6.2
PrimateAI
Pathogenic
0.88
D
PROVEAN
Uncertain
-3.4
D;D;D;D;D;D;D
REVEL
Pathogenic
0.68
Sift
Uncertain
0.0020
D;D;D;D;D;D;D
Sift4G
Uncertain
0.013
D;D;D;D;D;D;D
Polyphen
0.99
D;D;.;.;.;D;.
Vest4
0.48
MutPred
0.55
Loss of phosphorylation at T230 (P = 0.1362);Loss of phosphorylation at T230 (P = 0.1362);.;.;.;Loss of phosphorylation at T230 (P = 0.1362);.;
MVP
0.81
MPC
2.3
ClinPred
0.95
D
GERP RS
3.3
Varity_R
0.67
gMVP
0.96
Mutation Taster
=31/69
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs869312865; hg19: chr9-140051128; COSMIC: COSV104634782; COSMIC: COSV104634782; API